Exhibit 107

 

Calculation of Filing Fee Tables

 

Form S-1

(Form Type)

 

bioAffinity Technologies, Inc.

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered Securities

 

  

Security

Type

 

Security

Class

Title

 

Fee

Calculation

or

Carry

Forward

Rule

   Amount Registered    Proposed Maximum Offering Price Per Unit   Maximum Aggregate Offering Price   Fee Rate   Amount of Registration Fee 
Fees to be Paid  Equity 

Common Stock,

$0.000142857142857 par value per share(1)

   457(o)          $           15,000,000 (2)    0.0000927   $1390.50 (7)
      Over-Allotment Option   457(o)            $2,250,000 (2)(3)   0.0000927    208.58 (7)
   Other  Representative’s Warrants(4)   457(g)                    
   Equity  Common Stock, $0.0001 par value per share, issuable upon exercise of the Representative’s Warrants(5)   457(o)          $1,587,000 (2)   0.0000927   $147.11 (7)
   Other  Placement Agent’s Warrants(4)   457(g)                    
   Equity  Common Stock, $0.0001 par value per share, issuable upon exercise of the Placement Agent’s Warrants(6)   457(a)   369,791 (8)            0.0000927     
     Total Offering Amount         $18,837,000        $1,746.19 
     Total Fees Previously Paid                   $ 
     Net Fee Due                   $1,746.19 

 

  (1) This registration statement also includes an indeterminate number of securities that may become offered, issuable or sold to prevent dilution resulting from stock splits, stock dividends and similar transactions, which are included pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”).
     
  (2) Estimated solely for the purpose of computing the registration fee in accordance with Rule 457(o) under the Securities Act.
     
  (3) Includes the offering price of additional shares that the underwriters have the option to purchase to cover over-allotments, if any.
     
  (4) No fee required pursuant to Rule 457(g) under the Securities Act.
     
  (5) Represents warrants to purchase a number of securities equal to 8% of the shares of Common Stock sold in this offering at an exercise price equal to 115% of the public offering price per share.
     
  (6) Represents warrants to purchase 369,791 shares of Common Stock issued to our Placement Agent at an exercise price equal to the price in this Offering or $0.75 per share if the Company does not complete an initial public offering by the warrants’ maturity date.
     
  (7) Calculated pursuant to Rule 457(o) under the Securities Act based on an estimate of the proposed maximum aggregate offering price.
     
  (8) To be calculated and paid in accordance with Rule 457(a) under the Securities Act when the price in this Offering is determined.